Clinical Trial Update: Biological Standardization of Dactylis Glomerata Allergen Extract [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on the biological standardization of grass pollen (Dactylis glomerata) allergen extract; status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergy to Grass Pollen

Drugs mentioned

• Grass pollen (Dactylis glomerata) allergen extract (Dactylis glomerata allergen extract)

Snippet

Sponsor: Laboratorios Leti, S.L. | Conditions: Allergy to Grass Pollen (Dactylis Glomerata) | Phase 2 | Status: COMPLETED